Table 2 Schedule of enrolment, interventions, and assessments
TIMEPOINT | STUDY PERIOD | ||||
|---|---|---|---|---|---|
Enrolment | Baseline | Intervention | Follow-up | ||
T0 | T1 | T2 | |||
ENROLMENT: | |||||
 Eligibility screen | X |  |  |  |  |
 Informed consent | X |  |  |  |  |
 Allocation |  | X |  |  |  |
INTERVENTIONS: | |||||
 Intervention group |  |  | X |  |  |
 Control group |  |  | X |  |  |
ASSESSMENTS: | |||||
 Primary outcome | |||||
  Medication adherence (MARS-5) |  | X |  | X | X |
 Secondary outcomes | |||||
  Medication knowledge (PKMUQ) |  | X |  | X | X |
  Medication beliefs (BMQ) |  | X |  | X | X |
  Medication social support (MSSS) |  | X |  | X | X |
  Medication self-efficacy (SEAMS) |  | X |  | X | X |
  Medication skills (self-developed scale) |  | X |  | X | X |
  Medication treatment satisfaction (TSQM) |  | X |  | X | X |
  Treatment burden (TBQ) |  | X |  | X | X |
  Quality of life (EQ-5D-5L) |  | X |  | X | X |
  Utilisation of healthcare services (six-item questionnaire) |  | X |  |  | X |
 Potential covariates | |||||
  Socio-demographics (Patients questionnaire) |  | X |  |  |  |
  Number of prescribed medications (one-item question) |  | X |  |  |  |
  Disease burden (CIRS-G) |  | X |  |  |  |
  Depressive symptoms (PHQ-9) |  | X |  |  |  |